Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis

3 Dec 2014

Abstract excerpt

BACKGROUND: For the detection of malignant mesothelioma no single biomarker with reasonable sensitivity and specificity has been described so far. Mesothelin, the most prominent blood-based biomarker, is characterized by high specificity but low sensitivity. It might be reasonable to combine biomarkers of different molecular classes in order to improve the overall performance. The aim of this study was to assess...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aluminum toxicity and tolerance in plants and animals
Share to Cystic Fibrosis Research Advances
Share to Occupational and environmental lung diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25469901
DOI: 10.1371/journal.pone.0114483

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma DiagnosisPMID 25469901Read ↗

Discovery of new biomarkers for malignant mesotheliomaSemantic proximity Read ↗

Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.Semantic proximity Read ↗

Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.Semantic proximity Read ↗

Towards a Better Understanding of Mesothelioma: A Comprehensive Review of Diagnosis, Therapy and BiomarkersSemantic proximity Read ↗

Progress and challenges in Mesothelioma: From bench to bedside.Semantic proximity Read ↗

Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workersSemantic proximity Read ↗

Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).Semantic proximity Read ↗

Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesotheliomaSemantic proximity Read ↗

MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic ImplicationsSemantic proximity Read ↗

Matrix Metalloproteinases as Biomarkers and Treatment Targets in Mesothelioma: A Systematic Review.Semantic proximity Read ↗

Artichoke Phytocomplex Modulates Serum microRNAs in Patients Exposed to Asbestos: A First Step of a Phase II Clinical TrialSemantic proximity Read ↗

Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant MesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.